Monday, June 17, 2024

Tag: ReNetX Bio

ReNetX Bio Receives Fast Track Designation From U.S. FDA

Potential First-in-Class Therapy for Chronic Spinal Cord Injury NEW HAVEN, Conn., Jan. 08, 2020 (GLOBE NEWSWIRE) -- ReNetX Bio announced today that the U.S. Food and Drug...

Drug aims to help treat spinal cord injuries

Researchers at ReNetX Bio are hoping a new name, the potential for a new influx of cash on the horizon and a new chief...